Rucaparib Completed Phase 2 Trials for Pancreatic Ductal Adenocarcinoma / Malignant Neoplasm of Pancreas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02042378A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation